SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunex
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
656 41 0 IMNX
Emcee:  Michael Yang Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
506Near Competition is Amgen's Anakinra, plus a bunch of others. But, Imnx is wCacaito-3/24/2001
505Hi Jacob. Am responding to your post on IMNX following below. But first here iLemurHouse-3/24/2001
504<<< This means that diversification is crucial in this sector. I woulseminole-3/24/2001
503Jacob: A good post which I'd like to expand / comment on: 1) Valuation. Logain Ablar-3/24/2001
502<i>7. All the big pharms are getting into genomics/biotech, by buying and scaram(o)uche-3/23/2001
501re: IMNX: I was asked to look at IMNX on another thread, and I'm respondingJacob Snyder-3/23/2001
500Got me some at $11.seminole-3/23/2001
499IMNX's CEO should be guest on CNBC this morning around 10 to 10:30AM accordiThai Chung-3/23/2001
498There is no demand problem for Enbrel. The company can't make product fast LemurHouse-3/23/2001
497Hello Andrew I agree The story is huge.But the other real concern is the moneyD.Austin-3/23/2001
496I missed the beginning of the call as well. It's archived now, however, so.scaram(o)uche-3/22/2001
495Read the article below. The application for congestive heart failure was almost hoffy-3/22/2001
494Bought at 10. Trading position only, leaving my LT position alone. Hope to selLemurHouse-3/22/2001
493andrew, according to the npf(www.psoriasis.org), there are 7 million psoriaticssoftware salesperson-3/22/2001
492Richard, what's your take on the Nuvance results? Although they still have LemurHouse-3/22/2001
491PASI scoring was statistically significant for psoriatic arthritis (eom)scaram(o)uche-3/22/2001
490>> they seem to be having trouble setting it up. << They just said scaram(o)uche-3/22/2001
489Yeah, its down to the Enbrel story at this point, but that's still a pretty LemurHouse-3/22/2001
488but its dropping like a rock! I'll be buying as soon as it stops dropping --D.Austin-3/22/2001
487Its getting crushed after announcing bad news on Nuvance PhII trials, and that tLemurHouse-3/22/2001
486imnx getting molested AH,,trading at 9Brasco One-3/22/2001
485Thank you for you link. I am glad to see from it that Immunex is moving in the rblackmerlin-3/16/2001
484From Dow Jones: \\\\\\\\\\\\\\\ Immunex Sees No Market-Share Loss Due to EnbLemurHouse-3/10/2001
483Thanks for your info FredAlfred W. Post-3/10/2001
482The Seattle research facility has nothing to do with the Enbrel supply constrainLemurHouse-3/9/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News